The Side Effects of Weight Loss Injections: Myths, Facts and When to Act

The myth that stops people asking: 'the side effects must be terrible'

Scroll any forum thread on weight loss injections and you will find alarming accounts. They are real experiences, but they are not the full picture. The majority of side effects recorded in clinical trials were mild to moderate in severity and eased over time, particularly as the body settled into each dose level. The NHS patient information on tirzepatide describes the common effects plainly: nausea, vomiting, diarrhoea, constipation, indigestion, burping, fatigue and headache. For semaglutide the profile is similar, as the NHS semaglutide page confirms.

A question our prescribers hear most weeks is some version of: "Will I be sick the whole time?" The honest answer is that some people do feel nauseous, especially in the first week at a new dose. Many find it passes quickly. Eating smaller portions, staying well hydrated, and avoiding fatty or rich food at mealtimes helps a lot. The graduated dose schedule (starting at the lowest strength and moving up slowly) exists precisely to reduce the chance of a sharp GI reaction.

What the alarming forum posts rarely mention is that severe, persistent symptoms are the exception, not the rule. Reading about the full side-effect picture for weight loss injections in a clinical context gives a more balanced view than anecdotal threads. The myth to correct, then, is not that side effects exist (they do) but that they are inevitably severe or permanent.

When side effects are a signal to get medical help immediately

Most digestive discomfort from weight loss injections is self-limiting. Some symptoms, however, are a signal to stop and call for help.

Acute pancreatitis is uncommon but serious. In January 2026, the MHRA issued a Drug Safety Update specifically highlighting pancreatitis as a known risk with GLP-1 receptor agonist medicines. The symptom to watch for is severe, persistent abdominal pain, often described as a deep, constant ache that radiates through to the back, sometimes with vomiting. If that happens, do not wait to see whether it settles: seek urgent medical care and tell the treating clinician which medicine you take. You can report suspected side effects at any point through the MHRA Yellow Card scheme, which is open to patients and carers, not just healthcare professionals.

Other symptoms that warrant prompt attention: signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing, a widespread rash), symptoms of dehydration following severe vomiting or diarrhoea (dizziness, very dark urine, feeling faint), significant upper-right abdominal pain that could indicate gallbladder problems, and any new or worsening low mood or thoughts of self-harm. If you are ever unsure, NHS 111 is available around the clock.

For a deeper look at which side effects are considered serious and how to recognise them, our clinical team has outlined the key warning signs clearly.

Side effects by medicine: how tirzepatide and semaglutide compare in practice

Both Mounjaro and Wegovy work by slowing gastric emptying and reducing appetite, so their side-effect profiles overlap considerably. Nausea is the most frequently reported effect with both. There are, however, a few practical differences worth knowing.

Tirzepatide activates two receptor pathways (GIP and GLP-1), which may affect how the gastrointestinal system responds compared with semaglutide's single GLP-1 action. Clinical trial data suggests tolerability is broadly comparable. One practical consideration specific to tirzepatide: women taking the oral contraceptive pill should add a barrier method of contraception for the first four weeks of treatment and for four weeks after each dose increase, because gastric emptying changes may reduce pill absorption. The NHS England guidance on weight management injections sets this out clearly. No equivalent evidence exists for semaglutide affecting pill absorption, though using reliable contraception during treatment with either medicine is sensible given that neither is recommended during pregnancy.

Injection-site reactions (mild redness, itching or a small lump at the injection point) occur with both medicines and usually resolve quickly. Rotating the injection site each week (abdomen, thigh and upper arm are all suitable) reduces their frequency. Our guide to weight loss injections covers technique in more detail. For a structured comparison of the two medicines' effects, the overview of what to expect from weight loss injection drugs is a useful read alongside this page.

How clinical oversight changes the side-effect experience

Side effects do not happen in isolation from the clinical process. How they are managed (and whether they are spotted early) depends on who is monitoring you and how closely. At nume, every repeat order is reviewed by a GPhC-registered prescriber before it is dispensed; this is not a tick-box exercise. If your side-effect burden is significant, the review is the moment to address it: adjusting the timing of your dose, holding at a lower strength for longer, or reassessing the medicine altogether are all legitimate clinical options.

The side effects associated with weight loss injection drugs as a broader class are also worth understanding if you are deciding which treatment suits you. If you have questions about cost alongside safety, the cost of weight loss injections page sets out what a clinically supervised private service includes. You can also browse the weight loss treatments overview or read about our clinical team at our prescribers' profile. Side effects are part of the suitability conversation from the very first step, speak to our prescribers through the free consultation and get a complete picture before you decide.